ATTENADE Trademark

Trademark Overview

On Saturday, January 6, 2007, a trademark application was filed for ATTENADE with the United States Patent and Trademark Office. The USPTO has given the ATTENADE trademark a serial number of 77077497. The federal status of this trademark filing is REGISTERED AND RENEWED as of Sunday, December 11, 2016. This trademark is owned by Celgene Corporation. The ATTENADE trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the treatment of attention deficit hyperactivity disorder; pharmaceutical preparations for treatment of immunological, inflammatory and neurological disorders
attenade

General Information

Serial Number77077497
Word MarkATTENADE
Filing DateSaturday, January 6, 2007
Status800 - REGISTERED AND RENEWED
Status DateSunday, December 11, 2016
Registration Number3301238
Registration DateTuesday, October 2, 2007
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 17, 2007

Trademark Statements

Goods and Servicespharmaceutical preparations for the treatment of attention deficit hyperactivity disorder; pharmaceutical preparations for treatment of immunological, inflammatory and neurological disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, January 10, 2007
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCelgene Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Trademark Events

Event DateEvent Description
Friday, December 9, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, December 9, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, December 9, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, December 9, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, December 9, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, December 9, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sunday, December 11, 2016NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - MAILED
Sunday, December 11, 2016REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Sunday, December 11, 2016REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Sunday, December 11, 2016CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, October 3, 2016TEAS SECTION 8 & 9 RECEIVED
Sunday, October 2, 2016COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Tuesday, July 28, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 19, 2012NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, October 19, 2012REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, October 18, 2012CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, October 3, 2012TEAS SECTION 8 & 15 RECEIVED
Tuesday, October 2, 2007REGISTERED-PRINCIPAL REGISTER
Tuesday, July 17, 2007PUBLISHED FOR OPPOSITION
Wednesday, June 27, 2007NOTICE OF PUBLICATION
Thursday, June 14, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, June 14, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 13, 2007TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 13, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 13, 2007ASSIGNED TO LIE
Tuesday, May 29, 2007TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, April 30, 2007NON-FINAL ACTION E-MAILED
Monday, April 30, 2007NON-FINAL ACTION WRITTEN
Monday, April 23, 2007ASSIGNED TO EXAMINER
Wednesday, January 10, 2007NEW APPLICATION ENTERED IN TRAM

Related Keywords

attenade treatment preparations pharmaceutical inflammatory disorders immunological neurological hyperactivity attention deficit